Syngene International Ltd logo

Syngene International Ltd

NSE: SYNGENE BSE: 539268

₹417.50

+10.90 (2.68%)

Sat, 07 Nov 2026, 06:58 pm

mtf coin illustrationMTF 5xInvest in Syngene International Ltd with 5x LeverageBuy with MTFpremium button ring illustration
Market Cap (in Cr)16401.08
PE Ratio90.37
Dividend0.31
Commercial ServicesCommercial Services
Miscellaneous Commercial ServicesMiscellaneous Commercial Services
24.5K24.5K

Syngene International Share Price Live Chart

1 Day

+10.90 (2.68%)

No Result Found

Summary

  • Market Cap (in Cr)

    16724.01

  • Net Profit (in Cr)

    316.7

  • P/B

    3.25

  • Sector P/E

    63.24

  • P/E

    49.65

  • EV/EBITDA

    16.82

  • Debt/Equity (Industry)

    0.38

  • Interest Cover (Industry)

    3.52

  • ROCE (Industry)

    9.17

  • RONW (Industry)

    6.23

  • ROE

    7.78

  • ROCE

    9.52

  • Debt/Equity

    0.11

  • EPS (TTM)

    6.59

  • Dividend Yield

    0.30

  • Book Value

    120.37

  • Interest Cover

    10.85

Analysis

all

thumbs up icon

Pros

  • Performance (ROE) is expected to be above the current IN Life Sciences industry average.
  • Syngene International's revenue growth is expected to exceed the India market average.
  • Syngene International is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Syngene International is profitable, therefore cash runway is not a concern.
  • Syngene International is profitable, therefore cash runway is not a concern.
thumbs up icon

Cons

  • Unable to calculate sustainability of dividends as Syngene International has not reported any payouts.
  • Unable to evaluate Syngene International's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Syngene International's dividend against the top 25% market benchmark as the company has not reported any payouts.
  • Syngene International's earnings are expected to grow by 1.5% yearly, however this is not considered high growth (20% yearly).
  • Syngene International's earnings growth is positive but not above the India market average.

Read More

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersSEPT 2026JUN 2026MAR 2026DEC 2025SEPT 2025
Promoters52.5952.5952.6852.6852.68
FII10.1411.8213.9014.9616.31
DII29.3028.0226.4425.8424.62
Public7.977.586.986.526.38
Government00.00000

Read More

Technical Analysis

RSI

61.54

MACD

9.83

50 DMA

384.89

200 DMA

424.30

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic537.47463.07432.88388.67358.48314.27239.87
Fibonacci463.07434.65417.09388.67360.25342.69314.27
Camarilla423.16416.34409.52388.67395.88389.06382.24

Pivots Level: Classic

R3

+148.80

537.47

R2

+74.40

463.07

R1

+44.22

432.88

388.67
388.67
Pivot Point
LTP: 417.30

S1

-30.18

358.48

S2

-74.40

314.27

S3

-148.80

239.87

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    403.97

  • 20-EMA

    394.18

  • 30-EMA

    390.50

  • 50-EMA

    390.68

  • 100-EMA

    403.56

  • 200-EMA

    444.36

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
27 Oct 2026board-meetingsQuarterly Results
29 Apr 2026board-meetingsAccounts, Final Dividend
29 Apr 2026agm
29 Apr 2026dividend₹1.25 Dividend /Share26 Jun 2026
22 Jan 2026board-meetingsQuarterly Results
05 Nov 2025board-meetingsQuarterly Results, Half Yearly Results
27 May 2025dividendFinal Dividend - Rs. - 1.2527 Jun 2025
23 Apr 2025agm
23 Apr 2025dividend₹1.25 Dividend /Share27 Jun 2025
28 May 2024dividendFinal Dividend - Rs. - 1.2528 Jun 2024

Read More

Peer Comparison

Syngene International Ltd logo

Syngene International Ltd

Apollo Hospitals Enterprise Ltd logo

Apollo Hospitals Enterprise Ltd

Aster DM Quality Care Ltd logo

Aster DM Quality Care Ltd

Max Healthcare Institute Ltd logo

Max Healthcare Institute Ltd

Fortis Healthcare Ltd logo

Fortis Healthcare Ltd

Read More

Syngene International Ltd About

Syngene International is engaged in providing contract research and manufacturing services from lead generation to clinical supplies to pharmaceutical and biotechnology companies worldwide. Syngene’s services include integrated drug discovery and development capabilities in medicinal chemistry, biology, in vivo pharmacology, toxicology, custom synthesis, process R&D, cGMP manufacturing, formulation and analytical development along with Clinical development services.

Industry

Miscellaneous

Founded

1993

Headquarters

CEO

Kiran Mazumdar Shaw

Employees

Contact

Website icon

Website

http://www.syngeneintl.com

Email icon

Email

investor@syngeneintl.com; Mayank.Verma@syngeneintl

Phone icon

Phone

91-80-68915000/67758781

Location icon

Location

Biocon SEZ Biocon Park, Plot No 2 & 3 Bommasandra Inds, Bengaluru, Karnataka, 560099

Read More

Syngene International Ltd Company History

YearHistory
2020
  • Syngene ties up with HiMedia Laboratories to manufacture ELISA test kits for COVID-19.
  • Syngene joins global industry consortium to accelerate collaborative research in COVID-19 testing.
  • Syngene and PharmAust collaborate to manufacture GMP-grade Monepantel for Human Clinical Trials.
  • Bioprocessing Excellence Award 2020.
2021
  • Syngene receives India Pharma Awards 2021.
  • Syngene Ranked As One Of The Top 100 Indian Wealth Creators For 2021.
  • Syngene International extends long term research collaboration with Bristol Myers Squibb until 2030.
  • Syngene through Biocon Foundation partners with NIMHANS for BHUMI.
2022
  • Syngene International takes top honors at CMO Leadership Awards 2022 for contract manufacturing.
  • Syngene signs 10-year biologics manufacturing agreement with leading animal health company.
  • Syngene and the Research and Innovation Circle of Hyderabad (RICH) launch scholarship program for women studying STEM subjects.
2023
  • Winner of India's Best Managed Companies 2023 programme
  • Supply Chain Champion Award, 2023
  • Best Overall Sustainable Performance (Pharmaceutical) 2023
  • Biopharma Excellence Award (India Edition) 2023
  • Panbela announces issuance of new patent in Australia.
2024
  • Syngene received Pharmaceutical Technology Excellence Awards 2024.
  • Syngene received Asia Pacific Biologics CMO Excellence Awards 2024.
  • Syngene awarded CDMO Leadership Awards 2024.
  • Syngene secures silver rating in EcoVadis sustainability index, ranking in top 15% of assessed companies.
  • Syngene launches platform for rapid, enhanced protein production.
  • Syngene International named as one of India's Best Managed Companies by Deloitte India.

Read More

Deals

Client NameDeal TypeOrder SideQTYAvg PriceDate
MICROCURVES TRADING PRIVATE LIMITEDbulkBuy2766287481.930 Apr 2026
NK SECURITIES RESEARCH PRIVATE LIMITEDbulkBuy2160599486.430 Apr 2026
MICROCURVES TRADING PRIVATE LIMITEDbulkSell2766287482.0230 Apr 2026
NK SECURITIES RESEARCH PRIVATE LIMITEDbulkSell2160599486.6230 Apr 2026
BIOCON LIMITEDbulkSell8000000857.6810 Dec 2024
GOVERNMENT OF SINGAPOREblockBuy1579920056001 Feb 2023
BIOCON LIMITEDblockSell1920000056001 Feb 2023
MONETARY AUTHORITY OF SINGAPOREblockBuy340080056001 Feb 2023
BIOCON LIMITEDblockSell375000056001 Feb 2023
MOTILAL OSWAL MUTUAL FUNDblockBuy170000056001 Feb 2023

Read More

Syngene International Ltd News

Syngene CFO Deepak Jain to resign; SMP roles change

Syngene International CFO Deepak Jain resigns for personal reasons. Three executives, including Head of Strategy Ajay Tandon, see designation changes or exit effective October 2026.

27 Oct 2026

companies

Syngene Q2 net profit falls 52% YoY

Syngene International's Q2 net profit dropped to ₹322 million from ₹671 million YoY. Revenue declined 8.5% to ₹8.33 billion, missing analyst estimates of ₹587 million.

27 Oct 2026

companies

Syngene International: Pramuch Goel Resigns

Syngene International Ltd disclosed the resignation of Mr. Pramuch Goel, Head of Corporate Affairs & Communications, effective September 21, 2026. He leaves to pursue other career opportunities.

21 Sept 2026

companies

Syngene to host Bajaj AMC analyst meet on Sep 24

Syngene International Ltd will hold an online one-on-one meeting with Bajaj AMC on September 24, 2026. The company confirmed no UPSI will be disclosed during the session.

21 Sept 2026

companies

Syngene to host analyst meet on Sep 17

Syngene International Limited will hold a virtual one-on-one meeting with True Beacon PMS on September 17, 2026, at 12:00 pm. The company confirmed no UPSI will be disclosed.

11 Sept 2026

companies

Read More

Frequently Asked Questions

  • 1.What is the stock price of Syngene International Ltd?

    As of 08/11/2026 at 12:28 AM, Syngene International Ltd shares are trading at ₹417.50.

  • 2.What is the market cap. of Syngene International Ltd?

    As of 08/11/2026, the market capitalization of Syngene International Ltd is ₹16,401.08 crore.

  • 3.When was Syngene International Ltd founded?

    Syngene International Ltd was founded in 1993.

  • 4.What are the P/E and P/B ratios of Syngene International Ltd?

    As of 08/11/2026, Syngene International Ltd has a P/E ratio of 90.37 and a P/B ratio of 3.25.

  • 5.How can I buy shares of Syngene International Ltd?

    You can buy shares of Syngene International Ltd through Pocketful. Simply open a Demat account, complete your KYC, add funds, and place a buy order.

  • 6.What is the shareholding pattern of Syngene International Ltd?

    As of September,2026, promoters hold 52.59% in Syngene International Ltd, while FIIs, DIIs and public shareholders hold 10.14%, 29.30% and 7.97%, respectively.

  • 7.Does Syngene International Ltd pay dividends?

    Yes, Syngene International Ltd pays dividends to eligible shareholders. The latest dividend announced by the company was ₹₹1.25 Dividend /Share per share.

  • 8.What is the dividend yield of Syngene International Ltd?

    As of 08 November, 2026, the dividend yield of Syngene International Ltd stands at 0.31%.

  • 9.What are the latest financial results of Syngene International Ltd?

    For the financial year ended March 2025, Syngene International Ltd reported revenue of ₹3,636.00 crore and a net profit of ₹496.00 crore.

  • 10.What is the Stock symbol of Syngene International Ltd?

    SYNGENE is the stock symbol of Syngene International Ltd.

  • 11.Who is the CEO of Syngene International Ltd?

    The CEO of Syngene International Ltd is Kiran Mazumdar Shaw.

pocketful logo lightpocketful logo dark
PricingBecome a Partner
search icon
/

No results for ''

Popular search

  • popular search iconSuzlon Energy Ltd
  • popular search iconIndian Railway Finance Corporation Ltd
  • popular search iconTata Motors Ltd
  • popular search iconTata Steel Ltd
  • popular search iconRail Vikas Nigam Ltd

Recent search

      Log In
      search icon

      No results for ‘’

        Popular search

        • popular search iconSuzlon Energy Ltd
        • popular search iconIndian Railway Finance Corporation Ltd
        • popular search iconTata Motors Ltd
        • popular search iconTata Steel Ltd
        • popular search iconRail Vikas Nigam Ltd
        • popular search iconReliance Industries Ltd
        pocketful logo lightpocketful logo dark
        • Pricing
        • Become a Partner
        Log In
        • home icon
        • arrow iconstocks
        • arrow iconsyngene international ltd
        • Overview
        • Analysis
        • Financials
        • Ratios
        • shareholding
        • Technical Analysis
        • Corporate Actions
        • Peer Comparison
        • About
        • Company History
        • Deals
        • News
        • FAQs

        Open Your Free Demat Account Now!

        Step into a world of zero fees and limitless opportunities!

        pocketful logo
        • Quick Links

          • Open Demat Account
          • Pocketful Web
          • Pocketful App
          • Pricing
          • Authorised Person
          • Pocketful Calculators
          • Compliance Links
        • Pages

          • Tools
          • Blogs
          • ETF Screener
          • IPO
          • ETF
          • Bonds
          • Index Heat Map
        • Products

          • Stocks
          • Commodity
          • Subscription
          • Free Stock Screener
          • Pocketful GPT
          • MTF
          • Mutual Funds
        • Company

          • About us
          • Contact us
          • Terms and Conditions
          • Policies & Procedures
          • Privacy Policy
          • Disclosure
          • Careers
        • Socials

          • Facebook iconFacebook
          • Twitter iconTwitter
          • Instagram iconInstagram
          • LinkedIn iconLinkedIn
          • Youtube iconYoutube

        2022-25 Pocketful. All rights reserved, Built with in India

        Version -5.76

        app image 1app image 2

        Stocks:

        AllABCDEFGHIJKLMNOPQRSTUVWXYZ

        Explore

        Calculators
        Popular Calculators
        Group Stocks
        Asset Management Companies
        Popular Stocks
        Indian Indices
        Sector Wise Stocks
        IPO
        Share Market
        Best MF Schemes
        Platforms
        Resources
        Gold Rates in Top Cities
        Silver Rates in Top Cities

        Others:

        NSEBSECDSLNSDLSEBIMCXMSEINCDEXNSE IFSCINDIA INXAccount Closure FormDP Investor CharterBroker Investor Charter

        Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800